LCN2 and acute kidney injury: Many novel biomarkers, e.g., NGAL, kidney injury molecule 1, cystatin C, and interleukin-18, may help identify early AKI; however, a detailed understanding of the mechanism of kidney injury and the use of more than one biomarker may be required.